Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.

Fréneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, Al Ghuzlan A, Birolini MJ, Clough K, Sastre-Garau X.

Mod Pathol. 2002 Jun;15(6):641-6.

2.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
3.

Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.

Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M.

Cancer. 2000 Mar 1;88(5):1099-107.

PMID:
10699901
4.

An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.

Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S.

Breast Cancer Res Treat. 2005 May;91(2):113-9.

PMID:
15868438
5.

[Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].

Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D.

Bull Cancer. 2008 Jul-Aug;95(7):763-72. doi: 10.1684/bdc.2008.0640. French.

6.

Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.

Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA.

Cancer. 2009 Apr 15;115(8):1605-12. doi: 10.1002/cncr.24173.

7.

Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.

Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC Jr.

Cancer. 1999 Sep 15;86(6):990-6.

PMID:
10491525
8.

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.

Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.

J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8.

PMID:
15384064
9.

Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis.

Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE.

Ann Surg Oncol. 1999 Dec;6(8):756-61.

PMID:
10622503
10.
11.

Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.

Salem AA, Douglas-Jones AG, Sweetland HM, Mansel RE.

Eur J Surg Oncol. 2006 Jun;32(5):484-7. Epub 2006 Mar 29.

PMID:
16569493
12.

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.

Spanknebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS.

Am J Surg Pathol. 2005 Mar;29(3):305-17.

PMID:
15725798
13.

Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.

Nieuwenhuis EJ, van der Waal I, Leemans CR, Kummer A, Pijpers R, Castelijns JA, Brakenhoff RH, Snow GB.

Head Neck. 2005 Feb;27(2):150-8.

PMID:
15627261
14.

Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.

Motomura K, Egawa C, Komoike Y, Nagumo S, Koyama H, Inaji H.

Ann Surg Oncol. 2006 Jul;13(7):985-9. Epub 2006 May 18.

PMID:
16788761
15.

Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.

Nos C, Harding-MacKean C, Fréneaux P, Trie A, Falcou MC, Sastre-Garau X, Clough KB.

Br J Surg. 2003 Nov;90(11):1354-60.

PMID:
14598414
16.

[Modulation of the axillary lymph node dissection in breast cancer].

Procaccini E, Ruggiero R, Mansi L, Laprovitera AP, Rambaldi PF, Cuccurullo V, Ferrara A, Procaccini F, Zenone P.

Ann Ital Chir. 2003 Jan-Feb;74(1):21-8; discussion 28-9. Italian.

PMID:
12870278
17.

[Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].

Giard S, Chauvet MP, Houpeau JL, Baranzelli MC, Carpentier P, Fournier C, Belkacemi Y, Bonneterre J.

Gynecol Obstet Fertil. 2005 Apr;33(4):213-9. Epub 2005 Apr 7. French.

PMID:
15894205
18.

Analysis of sentinel node involvement in gastric cancer.

Morita D, Tsuda H, Ichikura T, Kimura M, Aida S, Kosuda S, Inazawa J, Mochizuki H, Matsubara O.

Clin Gastroenterol Hepatol. 2007 Sep;5(9):1046-52. Epub 2007 Jul 13.

PMID:
17632042
19.

Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure.

Tjan-Heijnen VC, Buit P, de Widt-Evert LM, Ruers TJ, Beex LV.

Breast Cancer Res Treat. 2001 Nov;70(2):81-8. Review.

PMID:
11768607
20.

Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.

Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R.

Breast J. 2004 Mar-Apr;10(2):101-5.

PMID:
15009035

Supplemental Content

Support Center